{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T12:40:15Z","timestamp":1792327215890,"version":"4.4.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":274,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101471","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:22:20Z","timestamp":1791991340000},"page":"101471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Age-related early mortality and competing-risk outcomes in angioimmunoblastic T-cell lymphoma: a SEER-based population study"],"prefix":"10.1016","volume":"49","author":[{"given":"Yingdan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3224-1733","authenticated-orcid":false,"given":"Huijing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101471_bib0001","first-page":"1720","volume":"36","author":"Alaggio","year":"2022"},{"key":"10.1016\/j.ctarc.2026.101471_bib0002","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101471_bib0003","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood-2016-09-692541","article-title":"Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma","volume":"129","author":"Lunning","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101471_bib0004","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1038\/s41375-020-0990-y","article-title":"Advances in understanding of angioimmunoblastic T-cell lymphoma","volume":"34","author":"Chiba","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.ctarc.2026.101471_bib0005","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101471_bib0006","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","article-title":"IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101471_bib0007","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.2916","article-title":"A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma","volume":"46","author":"Yoo","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ctarc.2026.101471_bib0008","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with AITL treated within GELA trials","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101471_bib0009","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood-2011-08-374371","article-title":"Retrospective analysis of prognostic factors for AITL: a multicenter cooperative study in Japan","volume":"119","author":"Tokunaga","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101471_bib0010","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","article-title":"Clinicopathologic characteristics of AITL: analysis of the International Peripheral T-Cell Lymphoma Project","volume":"31","author":"Federico","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101471_bib0011","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1182\/blood.2020010387","article-title":"Outcomes and prognostic factors in AITL: final report from the International T-Cell Project","volume":"138","author":"Advani","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101471_bib0012","article-title":"No survival improvement for patients with AITL over the past two decades: a population-based study of 1207 cases","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ctarc.2026.101471_bib0013","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1007\/s11596-022-2651-z","article-title":"Incidence, survival outcome, and prognostic nomogram of patients with AITL: a population-based analysis","volume":"42","author":"Chen","year":"2022","journal-title":"Curr. Med. Sci."},{"key":"10.1016\/j.ctarc.2026.101471_bib0014","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00277-026-06796-6","article-title":"Radiotherapy in addition to systemic therapy reduces the early mortality of AITL","volume":"105","author":"Lin","year":"2026","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ctarc.2026.101471_bib0016","first-page":"169","article-title":"Clinical features and outcomes of AITL: a retrospective study of 312 patients in China","volume":"12","author":"Wei","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.ctarc.2026.101471_bib0015","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/sim.7501","article-title":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data","volume":"36","author":"Austin","year":"2017","journal-title":"Stat. Med."},{"key":"10.1016\/j.ctarc.2026.101471_bib0017","unstructured":"National Cancer Institute. SEER Lymphomas - Ann Arbor Staging (1983-2015). 2026 Available at: https:\/\/seer.cancer.gov\/seerstat\/variables\/seer\/ajcc-stage\/ann-arbor\/."},{"key":"10.1016\/j.ctarc.2026.101471_bib0018","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1200\/JCO.20.02465","article-title":"Simplified geriatric assessment in older patients with diffuse large B-cell lymphoma: the prospective elderly project of the Fondazione Italiana Linfomi","volume":"39","author":"Merli","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101471_bib0019","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jgo.2022.02.005","article-title":"Geriatric assessment in older adults with non-Hodgkin lymphoma: a YSIOG review paper","volume":"13","author":"Akhtar","year":"2022","journal-title":"J. Geriatr. Oncol."},{"key":"10.1016\/j.ctarc.2026.101471_bib0020","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ejon.2014.05.006","article-title":"Validation of the G8 screening tool in older patients with aggressive haematological malignancies","volume":"18","author":"Velghe","year":"2014","journal-title":"Eur. J. Oncol. Nurs."},{"key":"10.1016\/j.ctarc.2026.101471_bib0021","first-page":"2194","article-title":"Multicenter phase 2 study of oral azacitidine plus CHOP as initial treatment for peripheral T-cell lymphoma","volume":"141","author":"Ruan","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101471_bib0022","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1182\/bloodadvances.2020002396","article-title":"T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed\/refractory peripheral T-cell lymphoma","volume":"4","author":"Ghione","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.ctarc.2026.101471_bib0023","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.annonc.2021.12.002","article-title":"ECHELON-2: 5-year results of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma","volume":"33","author":"Horwitz","year":"2022","journal-title":"Ann. Oncol."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T11:45:20Z","timestamp":1792323920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226003801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":23,"alternative-id":["S2468294226003801"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101471","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age-related early mortality and competing-risk outcomes in angioimmunoblastic T-cell lymphoma: a SEER-based population study","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101471"}}